Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07848789Phase 2Not yet recruiting
Phase 2, randomised, double-blind trial (2 arms), sponsored by icddr,b. Primary endpoint: Clinical cure (<3 liquid stools/24 hours after randomization) or Cessation of diarrhea (passage of soft/formed or no stool for consecutive two 8-hour periods) at 5 days. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07848789.